Elevated expression was significantly associated with poor clinical outcomes.<h4>Conclusions</h4>Phosphorylated TOP1, TOP2A, TOP2B, and C1orf35 are strongly associated with HCC progression and poor prognosis, highlighting their potential as prognostic biomarkers and therapeutic targets. The gene discussed is TOP2B; the disease is hepatocellular carcinoma.